1Inserm 1433, Centre d'Investigations Cliniques-Plurithématique, Université de Lorraine, CHU Nancy, 54500 France; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France; Association Lorraine de Traitement de l'Insuffisance Rénale, Nancy, France.
2University of Michigan School of Medicine, Ann Arbor, MI, USA.
3Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
4Inserm 1433, Centre d'Investigations Cliniques-Plurithématique, Université de Lorraine, CHU Nancy, 54500 France; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
0Inserm 1433, Centre d'Investigations Cliniques-Plurithématique, Université de Lorraine, CHU Nancy, 54500 France; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France; Association Lorraine de Traitement de l'Insuffisance Rénale, Nancy, France.
Lancet (London, England) +
|
2016年10月30日
関連する実験動画
These videos have been matched automatically. Contact us if they are not relevant.
